0001477932-13-001150.txt : 20130314 0001477932-13-001150.hdr.sgml : 20130314 20130314153611 ACCESSION NUMBER: 0001477932-13-001150 CONFORMED SUBMISSION TYPE: NT 10-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121231 FILED AS OF DATE: 20130314 DATE AS OF CHANGE: 20130314 EFFECTIVENESS DATE: 20130314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCORAL INC CENTRAL INDEX KEY: 0000919605 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE OPERATORS (NO DEVELOPERS) & LESSORS [6510] IRS NUMBER: 330601504 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34059 FILM NUMBER: 13690363 BUSINESS ADDRESS: STREET 1: 12/14 RUE RAYMOND RIDEL CITY: 92250 LA GARENNE COLOMBES STATE: I0 ZIP: 00000 BUSINESS PHONE: 01133147579843 MAIL ADDRESS: STREET 1: 12/14 RUE RAYMOND RIDEL CITY: 92250 LA GARENNE COLOMBES STATE: I0 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: IMMO FINANCE CORP DATE OF NAME CHANGE: 19940420 FORMER COMPANY: FORMER CONFORMED NAME: HERMENEUTICS CORP DATE OF NAME CHANGE: 19940301 NT 10-K 1 bcra_nt10k.htm NT 10-K bcra_nt10k.htm


United States
Securities and Exchange Commission
Washington, D.C. 20549
 
FORM 12b-25
Notification of Late Filing
(Amendment No.    0   )*
 
OMB Number
3235-0058
 
SEC File Number
0-23512
 
CUSIP Number
 
(Check one):
þ Form 10-K
 
¨ Form 20-F
 
¨ Form 11-K
 
¨ Form 10-Q
 
¨ Form 10-D
 
¨ Form N-SAR
 
 
o Form N-CSR
                     
 
For Period Ended:  December 31, 2012
                 
 
 
¨
Transition Report on Form 10-K
 
¨
Transition Report on Form 20-F
 
¨
Transition Report on Form 11-K
 
¨
Transition Report on Form 10-Q
 
¨
Transition Report on Form N-SAR
 
For the Transition Period Ended: _______________________
 
 
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
 
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
 


Part I - Registrant Information

BIOCORAL, INC.
Full Name of Registrant
 
 
Former Name if Applicable
 
12-14 Rue Raymond Ridel
Address of Principal Executive Office (Street and Number)
 
La Garenne Colombes 92250 - France
City, State and Zip Code

 
 

 
Part II - Rules 12b-25(b) and (c)
 
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

 
(a)
 
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense.
 
þ
(b)
 
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
 
 
(c)
 
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
 
Part III - Narrative

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q,10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
 
The registrant is unable to file the subject report in a timely manner because the registrant was not able to complete timely its financial statements without unreasonable effort or expense.

(Attach extra Sheets if Needed)
 
Part IV - Other Information

1.
Name and telephone number of person to contact in regard to this notification

Nasser Nassiri
 
011-331
 
4757-9843
(Name)
 
(Area Code)
 
(Telephone Number)

2.
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?

Yes  þ  No  ¨
 
 
If answer is no, identify report(s).
 

 
3.
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

Yes  ¨  No  þ
 
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 
2

 
 
BIOCORAL, INC.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized
 
 
Date:  03-14-2013
By:   /s/
Nasser Nassiri
Title:    
President
         
 
INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.
 
 Attention
Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).
 
 
3